Predicting conversion to Alzheimer’s disease in individuals with Mild Cognitive Impairment using clinically transferable features

Abstract Patients with Mild Cognitive Impairment (MCI) have an increased risk of Alzheimer’s disease (AD). Early identification of underlying neurodegenerative processes is essential to provide treatment before the disease is well established in the brain. Here we used longitudinal data from the ADN...

Full description

Bibliographic Details
Main Authors: Ingrid Rye, Alexandra Vik, Marek Kocinski, Alexander S. Lundervold, Astri J. Lundervold
Format: Article
Language:English
Published: Nature Portfolio 2022-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-18805-5
_version_ 1798036364597395456
author Ingrid Rye
Alexandra Vik
Marek Kocinski
Alexander S. Lundervold
Astri J. Lundervold
author_facet Ingrid Rye
Alexandra Vik
Marek Kocinski
Alexander S. Lundervold
Astri J. Lundervold
author_sort Ingrid Rye
collection DOAJ
description Abstract Patients with Mild Cognitive Impairment (MCI) have an increased risk of Alzheimer’s disease (AD). Early identification of underlying neurodegenerative processes is essential to provide treatment before the disease is well established in the brain. Here we used longitudinal data from the ADNI database to investigate prediction of a trajectory towards AD in a group of patients defined as MCI at a baseline examination. One group remained stable over time (sMCI, n = 357) and one converted to AD (cAD, n = 321). By running two independent classification methods within a machine learning framework, with cognitive function, hippocampal volume and genetic APOE status as features, we obtained a cross-validation classification accuracy of about 70%. This level of accuracy was confirmed across different classification methods and validation procedures. Moreover, the sets of misclassified subjects had a large overlap between the two models. Impaired memory function was consistently found to be one of the core symptoms of MCI patients on a trajectory towards AD. The prediction above chance level shown in the present study should inspire further work to develop tools that can aid clinicians in making prognostic decisions.
first_indexed 2024-04-11T21:11:50Z
format Article
id doaj.art-4ce92f170b3b4020b80fb2206a6c59bb
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-11T21:11:50Z
publishDate 2022-09-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-4ce92f170b3b4020b80fb2206a6c59bb2022-12-22T04:03:00ZengNature PortfolioScientific Reports2045-23222022-09-0112111110.1038/s41598-022-18805-5Predicting conversion to Alzheimer’s disease in individuals with Mild Cognitive Impairment using clinically transferable featuresIngrid Rye0Alexandra Vik1Marek Kocinski2Alexander S. Lundervold3Astri J. Lundervold4Department of Biological and Medical Psychology, University of BergenMohn Medical Imaging and Visualization Centre (MMIV), Department of Radiology, Haukeland University HospitalMohn Medical Imaging and Visualization Centre (MMIV), Department of Radiology, Haukeland University HospitalMohn Medical Imaging and Visualization Centre (MMIV), Department of Radiology, Haukeland University HospitalDepartment of Biological and Medical Psychology, University of BergenAbstract Patients with Mild Cognitive Impairment (MCI) have an increased risk of Alzheimer’s disease (AD). Early identification of underlying neurodegenerative processes is essential to provide treatment before the disease is well established in the brain. Here we used longitudinal data from the ADNI database to investigate prediction of a trajectory towards AD in a group of patients defined as MCI at a baseline examination. One group remained stable over time (sMCI, n = 357) and one converted to AD (cAD, n = 321). By running two independent classification methods within a machine learning framework, with cognitive function, hippocampal volume and genetic APOE status as features, we obtained a cross-validation classification accuracy of about 70%. This level of accuracy was confirmed across different classification methods and validation procedures. Moreover, the sets of misclassified subjects had a large overlap between the two models. Impaired memory function was consistently found to be one of the core symptoms of MCI patients on a trajectory towards AD. The prediction above chance level shown in the present study should inspire further work to develop tools that can aid clinicians in making prognostic decisions.https://doi.org/10.1038/s41598-022-18805-5
spellingShingle Ingrid Rye
Alexandra Vik
Marek Kocinski
Alexander S. Lundervold
Astri J. Lundervold
Predicting conversion to Alzheimer’s disease in individuals with Mild Cognitive Impairment using clinically transferable features
Scientific Reports
title Predicting conversion to Alzheimer’s disease in individuals with Mild Cognitive Impairment using clinically transferable features
title_full Predicting conversion to Alzheimer’s disease in individuals with Mild Cognitive Impairment using clinically transferable features
title_fullStr Predicting conversion to Alzheimer’s disease in individuals with Mild Cognitive Impairment using clinically transferable features
title_full_unstemmed Predicting conversion to Alzheimer’s disease in individuals with Mild Cognitive Impairment using clinically transferable features
title_short Predicting conversion to Alzheimer’s disease in individuals with Mild Cognitive Impairment using clinically transferable features
title_sort predicting conversion to alzheimer s disease in individuals with mild cognitive impairment using clinically transferable features
url https://doi.org/10.1038/s41598-022-18805-5
work_keys_str_mv AT ingridrye predictingconversiontoalzheimersdiseaseinindividualswithmildcognitiveimpairmentusingclinicallytransferablefeatures
AT alexandravik predictingconversiontoalzheimersdiseaseinindividualswithmildcognitiveimpairmentusingclinicallytransferablefeatures
AT marekkocinski predictingconversiontoalzheimersdiseaseinindividualswithmildcognitiveimpairmentusingclinicallytransferablefeatures
AT alexanderslundervold predictingconversiontoalzheimersdiseaseinindividualswithmildcognitiveimpairmentusingclinicallytransferablefeatures
AT astrijlundervold predictingconversiontoalzheimersdiseaseinindividualswithmildcognitiveimpairmentusingclinicallytransferablefeatures